Uncategorized

As therapies for rare and neurological diseases earn accelerated approval, experts laud the program’s intent while remaining concerned about confirmatory trials and clinical efficacy, especially as products greenlit under this pathway are pulled from the market.

  iStock   El iPhone 16 Pro ha sido diseñado para quienes buscan un rendimiento superior y un diseño refinado, que se adapte tanto al uso cotidiano como a las tareas más exigentes. Este smartphone ofrece mejoras en su resistencia y en su capacidad para ejecutar ap …

Like other payers, Centene flagged a mismatch between patient acuity and payment rates in Medicaid. But the insurer said a diversified portfolio helped it navigate challenges in the third quarter.  

Teri Lawver is leaving the diabetes tech company during a challenging time, with sales slowing after a salesforce restructuring.

Hurt by a slowdown in procedures for its heart valve replacement devices, Edwards said it is working with hospitals to manage workflow challenges.

Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

Home health is already a lucrative market, and Providence expects demand for services to only grow as patients age, according to CFO Greg Hoffman.

Baxter still does not have a timeline for fully restoring production at the North Carolina facility, which was hit by Hurricane Helene.

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the company’s leadership. However, analysts are supportive of the embattled executive.

Analysts expect Kamala Harris to largely continue the current approach to AI oversight, while Donald Trump’s promise to repeal a Biden executive order signals a major shift.